Le Lézard
Classified in: Health
Subject: SVY

Global Circulating Tumor Cell (CTC) Diagnostics Market to 2021 - Market to Grow at a CAGR of 9.39%


DUBLIN, October 18, 2017 /PRNewswire/ --

The "Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global circulating tumor cell (CTC) diagnostics market to grow at a CAGR of 9.39% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global circulating tumor cell (CTC) diagnostics market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The report also includes a discussion of the Key vendors operating in this market.

One trend in the market is introduction of advanced detection technologies. Cancer is a lethal disease taking toll across the geographical regions. The use of advanced technologies has helped in early diagnosis of cancer and improved treatment in patients. Diagnostic imaging technology has introduced molecular imaging technique for the detection of cancerous cells.

According to the report, one driver in the market is increasing incidences of cancer. Cancer is one of the lethal diseases, which has increased mortality rate worldwide. Various types of cancer occur due to genetic changes, high consumption of alcohol, smoking, and other lifestyle changes. The overall burden of cancer is increasing across the globe.

Further, the report states that one challenge in the market is high cost of diagnostics. Cancer treatment covers the majority of healthcare expenditure in most of the countries across the world. Cancer drug expenditure is also increasing in the countries.

Key Market Trends

Key vendors

Other prominent vendors

Key Topics Covered:

  1. Executive Summary
  2. Scope Of The Report
  3. Research Methodology
  4. Introduction
  5. Market Landscape
  6. Market Segmentation By End-User
  7. Geographical Segmentation
  8. Decision Framework
  9. Drivers And Challenges
  10. Market Trends
  11. Vendor Landscape
  12. Key Vendor Analysis
  13. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/d94qf7/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: